Cargando…
A novel, flexible and automated manufacturing facility for cell-based health care products: Tissue Factory
INTRODUCTION: Current production facilities for Cell-Based Health care Products (CBHPs), also referred as Advanced-Therapy Medicinal Products or Regenerative Medicine Products, are still dependent on manual work performed by skilled workers. A more robust, safer and efficient manufacturing system wi...
Autores principales: | Kikuchi, Tetsutaro, Kino-oka, Masahiro, Wada, Masanori, Kobayashi, Toyoshige, Kato, Midori, Takeda, Shizu, Kubo, Hirotsugu, Ogawa, Tetsuya, Sunayama, Hironobu, Tanimoto, Kazuhito, Mizutani, Manabu, Shimizu, Tatsuya, Okano, Teruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223031/ https://www.ncbi.nlm.nih.gov/pubmed/30525079 http://dx.doi.org/10.1016/j.reth.2018.08.004 |
Ejemplares similares
-
Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products
por: Mizutani, Manabu, et al.
Publicado: (2022) -
Understanding the formation and behaviors of droplets toward consideration of changeover during cell manufacturing
por: Ogawa, Yuuki, et al.
Publicado: (2019) -
Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act
por: Mizutani, Manabu, et al.
Publicado: (2016) -
Variation in the manufacturing reproducibility of autologous cell-based products depending on raw material shipment conditions
por: Mizutani, Manabu, et al.
Publicado: (2019) -
Preface of the special issue “Cell Manufacturability”
por: Kino-oka, Masahiro, et al.
Publicado: (2019)